Development of an exon 27-skipping antisense oligonucleotide as a targeted therapy for refractory skin ulcers in Werner syndrome
- DOI
- 10.1016/j.omtn.2026.102930
- Published
- 2026-06
- Container
- Molecular Therapy Nucleic Acids
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.omtn.2026.102930,
title = {Development of an exon 27-skipping antisense oligonucleotide as a targeted therapy for refractory skin ulcers in Werner syndrome},
author = {Zhiqiu Man and Shigehiro Asano and Tomomi Kakutani and Akihiko Kiyoshi and Kyosuke Hino and Atsushi Ikeda},
year = {2026},
journal = {Molecular Therapy Nucleic Acids},
doi = {10.1016/j.omtn.2026.102930},
url = {https://doi.org/10.1016/j.omtn.2026.102930}
}RIS
TY - JOUR TI - Development of an exon 27-skipping antisense oligonucleotide as a targeted therapy for refractory skin ulcers in Werner syndrome AU - Zhiqiu Man AU - Shigehiro Asano AU - Tomomi Kakutani AU - Akihiko Kiyoshi AU - Kyosuke Hino AU - Atsushi Ikeda PY - 2026 JO - Molecular Therapy Nucleic Acids DO - 10.1016/j.omtn.2026.102930 UR - https://doi.org/10.1016/j.omtn.2026.102930 ER -
APA
Man, Z., Asano, S., Kakutani, T., Kiyoshi, A., Hino, K., & Ikeda, A. (2026). Development of an exon 27-skipping antisense oligonucleotide as a targeted therapy for refractory skin ulcers in Werner syndrome. Molecular Therapy Nucleic Acids. https://doi.org/10.1016/j.omtn.2026.102930
Source records
- crossref · retrieved 2026-09-26T14:55:40.531Z